Non-invasive identification of steatohepatitis in patients with MASLD using a sterol and lipidomic signature
Journal of Lipid Research · 2025
DOI: 10.1016/j.jlr.2025.100845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Ratna Budhi Pebriana und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pharmaceutical Chemistry, Faculty of…. Hauptthemen laut MEDLINE: Lipidomics, Fatty Liver, Sterols. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lembaga Pengelola Dana Pendidikan, Kementerian Keuangan Republik Indonesia, Dutch Research Council.
Abstract (Originalsprache)
The accumulation of cholesterol and other lipids leading to hepatic lipotoxicity drives the progression of metabolic dysfunction-associated steatotic liver (MASL) to metabolic dysfunction-associated steatohepatitis (MASH), the advanced progressive stage of metabolic dysfunction-associated steatotic liver disease (MASLD). For MASH diagnosis, liver biopsy remains the reference standard, despite its invasiveness and limitations. Thus, this study aimed to find blood-derived lipid markers for MASH. We investigated serum samples from 86 patients with histologically characterized MASLD, spanning the disease spectrum (i.e. 62 patients with MASL (Fibrosis grade 0-4) and 24 patients with MASH (Fibrosis grade 2-4) with a balanced distribution of hepatocellular carcinoma) and analyzed sterol composition and lipidome. To identify the presence of MASH, logistic regression was performed on each candidate either in a single or combination with various clinical parameters. Serum levels of desmosterol and phosphatidylcholine are increased in patients with MASH compared to those with MASL. After exclusion of patients using lipid lowering drugs, an increase was also found in serum levels of cholesterol, cholesterol ester, lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylethanolamine, and several individual lipid species. The ROC curve of each lipid candidate show the potential use of desmosterol, phosphatidylcholine, and a panel of lipid species in combination with alanine aminotransferase as potential diagnostic markers, characterized by a respective AUROC of 0.79 (95% CI 0.66-0.92), 0.80 (95% CI 0.64-0.97), and 0.91 (95% CI 0.82-1.00). Serum sterol and lipidome markers are characterized by strong AUROC results to distinguish with high accuracy MASH from MASL, potentially paving the way for future MASH biomarker development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
- Division of Experimental Vascular Medicine, Department of Internal Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Pathology, Amsterdam UMC, Amsterdam, The Netherlands.
- Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.
- Division of Endocrinology, Department of Medicine, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Förderung
- Lembaga Pengelola Dana Pendidikan
- Kementerian Keuangan Republik Indonesia
- Dutch Research Council
- European Commission
- Ministrstvo za visoko šolstvo, znanost in tehnologijo
- European Research Council
Zitieren
APA
Pebriana, R. B., Chen, T., Derks, R. J. E., Blomberg, N., Grefhorst, A., Mohammed, Y., Nieuwdorp, M., Verheij, J., Doukas, M., Rensen, P. C. N., Holleboom, A. G., Tushuizen, M. E., & Giera, M. (2025). Non-invasive identification of steatohepatitis in patients with MASLD using a sterol and lipidomic signature. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100845
Vancouver
Pebriana RB, Chen T, Derks RJE, Blomberg N, Grefhorst A, Mohammed Y, et al. Non-invasive identification of steatohepatitis in patients with MASLD using a sterol and lipidomic signature. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100845
BibTeX
@article{Pebriana2025,
author = {Pebriana, Ratna Budhi and Chen, Ting and Derks, Rico J E and Blomberg, Niek and Grefhorst, Aldo and Mohammed, Yassene and Nieuwdorp, Max and Verheij, Joanne and Doukas, Michail and Rensen, Patrick C N and Holleboom, Adriaan G and Tushuizen, Maarten E and Giera, Martin},
title = {Non-invasive identification of steatohepatitis in patients with MASLD using a sterol and lipidomic signature},
journal = {Journal of Lipid Research},
year = {2025},
doi = {10.1016/j.jlr.2025.100845}
}
EUVIMED